Stock BCAB BIOATLA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions BioAtla, Inc.

Equities

BCAB

US09077B1044

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
2.71 USD -6.87% Intraday chart for BioAtla, Inc. -16.62% +10.16%
May. 06 BioAtla's Multiple Cancer Drug Candidate Receives FDA Clearance MT
May. 06 BioAtla Announces FDA Clearance of Investigational New Drug Application for BA3361, a CAB-Nectin-4 Antibody Drug Conjugate for the Treatment of Multiple Tumors CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. BCAB Stock
  4. Revisions BioAtla, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW